Search -

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation TCT 2025

TCT 628: Ascending Aorta is the Key Predictor for Pure Native Aortic Regurgitation Patients Underwent Self-expandable Transfemoral Transcatheter Aortic Valve Replacement : From the Multicenter National NTCVR Database in China

Presenter: Xiaochun Zhang

October 28, 2025

Presentation TCT 2025

Transcatheter Treatment of Chronic Aortic Regurgitation Using the Novel J-Valve System: 6-Months Results from a Transfemoral Early Feasibility Study (Edwards Lifesciences)

Presenter: Santiago Garcia

October 27, 2025

Presentation TCT 2025

The Transfemoral TaurusNXT TAVR System (Peijia Medical): Two-Year Results of the NXT-DURA Trial

Presenter: Wenzhi Pan

October 27, 2025

Presentation TCT 2025

TCT 1146: Transfemoral Transcatheter Aortic Valve Replacement in native aortic valves with small annuli: comparison of self-expandable and balloon-expandable vales.

Presenter: Kimberley Hemelrijk

October 25, 2025

News Conference News NY Valves 2025

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Todd Neale

June 27, 2025

Presentation NY Valves 2025

Transradial vs Transfemoral Secondary Access for Transfemoral TAVR

Presenter: Chidubem Ezenna

June 27, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Daily News

Reinterventions Rare Yet Predictable After TAVI, French Registries Show

Caitlin E. Cox

March 05, 2025

Advertisement

TCT 628: Ascending Aorta is the Key Predictor for Pure Native Aortic Regurgitation Patients Underwent Self-expandable Transfemoral Transcatheter Aortic Valve Replacement : From the Multicenter National NTCVR Database in China

Transcatheter Treatment of Chronic Aortic Regurgitation Using the Novel J-Valve System: 6-Months Results from a Transfemoral Early Feasibility Study (Edwards Lifesciences)

The Transfemoral TaurusNXT TAVR System (Peijia Medical): Two-Year Results of the NXT-DURA Trial

TCT 1146: Transfemoral Transcatheter Aortic Valve Replacement in native aortic valves with small annuli: comparison of self-expandable and balloon-expandable vales.

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Transradial vs Transfemoral Secondary Access for Transfemoral TAVR

April 2025 Dispatch for the CV Team

Reinterventions Rare Yet Predictable After TAVI, French Registries Show

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content